Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
Clinical trial NCT00419146 · COMPLETED
Trial details
- NCT number
- NCT00419146
- Sponsor
- University Hospital, Aker
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2004-04-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.